Serum biomarkers for detection of breast cancers: A prospective study.
about
Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approachCollagen VI and hyaluronan: the common role in breast cancerMass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer.Early diagnostic protein biomarkers for breast cancer: how far have we come?Proteomic approach to breast cancer.Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.SELDI-TOF serum proteomics and breast cancer: which perspective?Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control studyDo serum biomarkers really measure breast cancer?Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.Challenges to developing proteomic-based breast cancer diagnostics.Clinical proteomics of breast cancerIdentification of serum protein markers for breast cancer relapse with SELDI-TOF MS.Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control studyPrimary study of lymph node metastasis-related serum biomarkers in breast cancer.Reproducible cancer biomarker discovery in SELDI-TOF MS using different pre-processing algorithms.Proteomic serum biomarkers and their potential application in cancer screening programs.Search for breast cancer biomarkers in fractionated serum samples by protein profiling with SELDI-TOF MS.Analysis of the differences of serum protein mass spectrometry in patients with triple negative breast cancer and non-triple negative breast cancer.Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery.Non-invasive proteomics-thinking about personalized breast cancer screening and treatmentMolecular profiling in the age of cancer genomics.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Methodology and applications of disease biomarker identification in human serum.Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.Metabolomics for the masses: The future of metabolomics in a personalized world.
P2860
Q24337286-32596143-1F3B-4780-836B-F157259B5EFDQ27011319-2451FB46-AFA8-4C96-A1D7-CA1767F355ADQ30985472-AE190539-8B40-4708-AC5F-E239E11F6095Q31043570-D4CD0C2F-1B4E-4D8E-AEA9-3BC5E8BA7CCAQ33301436-937A0391-70FF-4EBB-A959-BB04A716A142Q33304365-86539DFE-276F-4AB6-856F-4BD1D4E7D0E2Q33393365-9FAEBF91-2F21-4BDB-A08A-3D8073CC0DC8Q33400847-34F02C14-BAAC-4947-8CCD-6C0F350150DCQ33454967-452413B7-81F4-46E9-AE66-B40FFF54CFC1Q33481276-A6E282C0-9987-4A61-9850-20FC4379627BQ33822314-30E367BD-02FD-4E02-9103-CD9B1D462676Q33823926-639CCB7D-944B-4CFE-A48C-005AB48CE471Q33885885-AB6ACC67-EC95-476A-8DD0-2BF10892D6FDQ33891208-13860B38-A47C-4D8C-9D52-C22C98C35DF2Q33892389-64996554-B54E-4177-A446-1F4D432452EFQ34003835-EFA246BC-9303-4B3E-B613-8BE0989FB5BAQ34037335-E309855B-B316-42DB-8EAA-2B6D707C82F2Q34056239-A91E9DB8-96A5-4009-8F79-1F7DA26FFA9CQ34395996-5590F705-25AF-46F0-BF56-9D99B19F1BFFQ35169678-E98BDAD0-1FB7-4C3E-990E-65138A276B7CQ35196711-B2B686CF-5E25-4222-B2D9-01E6B38A21DBQ35226540-51C4014C-F343-46FC-B8AD-1DA9D0C776F6Q35637149-AB1250E0-D518-4B28-AD18-155734D000AAQ36117711-BA83C88E-7FBB-4B70-83B5-4D3552C29E96Q37206155-2CD66ED1-CAF9-4E34-820C-F61711078C42Q37484011-E782C572-30F1-4738-8DA5-B921084FBF43Q37574961-8F362BAD-D069-499E-A36E-1118642C77E8Q37960202-EC4CE479-2408-4DFA-88F3-21C939A32E9FQ44951888-9F9B06EC-D824-4775-BEF3-24638B832C05
P2860
Serum biomarkers for detection of breast cancers: A prospective study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Serum biomarkers for detection of breast cancers: A prospective study.
@ast
Serum biomarkers for detection of breast cancers: A prospective study.
@en
type
label
Serum biomarkers for detection of breast cancers: A prospective study.
@ast
Serum biomarkers for detection of breast cancers: A prospective study.
@en
prefLabel
Serum biomarkers for detection of breast cancers: A prospective study.
@ast
Serum biomarkers for detection of breast cancers: A prospective study.
@en
P2093
P1476
Serum biomarkers for detection of breast cancers: A prospective study.
@en
P2093
Anne Cromer
Carole Mathelin
Corinne Wendling
Marie-Christine Rio
P2888
P356
10.1007/S10549-005-9046-2
P407
P577
2006-03-01T00:00:00Z
P6179
1011923129